Torres, Gonzalo E.; Raul R. Gainetdinov, Marc G. Caron (enero de 2003). «Plasma Membrane Monoamine Transporters: Structure, Regulation and Function». Nature Reviews Neuroscience4 (1): 13-25. PMID12511858. doi:10.1038/nrn1008.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Fone, Kevin; David J Nutt (febrero de 2005). «Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder». Current Opinion in Pharmacology5 (1): 87-93. PMID15661631. doi:10.1016/j.coph.2004.10.001.
Nemeroff, Charles B.; Michael J. Owens (octubre de 2002). «Treatment of mood disorders». Nature neuroscience: 1068-1070. doi:10.1038/nn943.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Hahn, MK; RD Blakely (marzo de 2002). «Monoamine Transporter Gene Structure and Polymorphisms in Relation to Psychiatric and Other Complex Disorders». The Pharmacogenomics Journal2 (4): 217-235. PMID12196911. doi:10.1038/sj.tpj.6500106.
Zhou J, He R, Johnson KM, Ye Y, Kozikowski AP. Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization. Journal of Medicinal Chemistry. 2004 Nov 18;47(24):5821-4. doi10.1021/jm040117oPMID 15537337
He R, Kurome T, Giberson KM, Johnson KM, Kozikowski AP (2005). «Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors». J. Med. Chem.48 (25): 7970-9. PMID16335921. doi:10.1021/jm050694s.
Blough BE, Keverline KI, Nie Z, Navarro H, Kuhar MJ, Carroll FI (2002). «Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter». J. Med. Chem.45 (18): 4029-37. PMID12190324. doi:10.1021/jm020098n.
nature.com
Nemeroff, Charles B.; Michael J. Owens (octubre de 2002). «Treatment of mood disorders». Nature neuroscience: 1068-1070. doi:10.1038/nn943.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
nih.gov
ncbi.nlm.nih.gov
Torres, Gonzalo E.; Raul R. Gainetdinov, Marc G. Caron (enero de 2003). «Plasma Membrane Monoamine Transporters: Structure, Regulation and Function». Nature Reviews Neuroscience4 (1): 13-25. PMID12511858. doi:10.1038/nrn1008.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
Fone, Kevin; David J Nutt (febrero de 2005). «Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder». Current Opinion in Pharmacology5 (1): 87-93. PMID15661631. doi:10.1016/j.coph.2004.10.001.
Hahn, MK; RD Blakely (marzo de 2002). «Monoamine Transporter Gene Structure and Polymorphisms in Relation to Psychiatric and Other Complex Disorders». The Pharmacogenomics Journal2 (4): 217-235. PMID12196911. doi:10.1038/sj.tpj.6500106.
Zhou J, He R, Johnson KM, Ye Y, Kozikowski AP. Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization. Journal of Medicinal Chemistry. 2004 Nov 18;47(24):5821-4. doi10.1021/jm040117oPMID 15537337
He R, Kurome T, Giberson KM, Johnson KM, Kozikowski AP (2005). «Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors». J. Med. Chem.48 (25): 7970-9. PMID16335921. doi:10.1021/jm050694s.
Blough BE, Keverline KI, Nie Z, Navarro H, Kuhar MJ, Carroll FI (2002). «Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter». J. Med. Chem.45 (18): 4029-37. PMID12190324. doi:10.1021/jm020098n.
